Back to results
US 9,789,072 B2Granted
Therapeutic agents for use in the propylaxis and/or treatment of hyperkinetic movement disorders
AssigneeSOM Innovation Biotech, S.L.
InventorsNuria Gavalda Batalla, Raul Insa Boronat, Nuria Reig Bolano
Life of this patent
Estimating the term…
Abstract
(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine having the formula (IA), or a pharmaceutically acceptable salt thereof for the formulation of a pharmaceutical composition is useful for the prophylaxis and/or the treatment of hyperkinetic movement disorders associated with Huntington's disease, Wilson's disease, Tourette syndrome, restless leg syndrome, and tardive dyskinesia.
Claims17
A method of treatment of a hyperkinetic movement disorder comprising the steps of:
- administering a composition comprising a compound of formula (IA)
- or a pharmaceutically acceptable salt thereof for treatment of a hyperkinetic movement disorder to a subject in need thereof, wherein the hyperkinetic movement disorder is associated with a disease selected from a group consisting of Huntington's disease, Wilson's disease, Tourette syndrome, restless leg syndrome and tardive dyskinesia.
Dependencies are inferred from the claim text.